ENDRA Life Sciences (NDRA) Gains from Sales and Divestitures (2021)
ENDRA Life Sciences (NDRA) reported Gains from Sales and Divestitures of $3.9 million for Q4 2021.
ENDRA Life Sciences (NDRA) Gains from Sales and Divestitures (2021) Analysis & Trends
ENDRA Life Sciences (NDRA) has 1 years of Gains from Sales and Divestitures data on file, last reported at $3.9 million in Q4 2021.
- Gains from Sales and Divestitures for Q4 2021 came in at $3.9 million, changed N/A year-over-year; the trailing twelve-month figure through Dec 2021 was $3.9 million (changed N/A YoY), and the FY2021 annual result was $3.9 million, changed N/A from the prior year.
- Gains from Sales and Divestitures was little changed at $3.9 million in Q4 2021 per NDRA's latest filing.
- Over five years, Gains from Sales and Divestitures peaked at $3.9 million in Q4 2021 and troughed at $3.9 million in Q4 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Waters | 30,529.42 Bn | 30,528.96 Bn | 1.11 Bn |
| 2 | Thermo Fisher Scientific | 183.75 Bn | 180.50 Bn | 7.74 Bn |
| 3 | Danaher | 133.13 Bn | 127.43 Bn | 3.59 Bn |
| 4 | Idexx Laboratories | 46.14 Bn | 45.94 Bn | 722.74 Mn |
| 5 | Agilent Technologies | 38.20 Bn | 36.39 Bn | 990.00 Mn |
| 6 | Natera | 31.50 Bn | 30.40 Bn | 696.04 Mn |
| 7 | Iqvia Holdings | 31.34 Bn | 29.36 Bn | 1.36 Bn |
| 8 | Illumina | 24.51 Bn | 23.36 Bn | 721.00 Mn |
| 9 | Mettler Toledo International | 23.53 Bn | 23.47 Bn | 555.82 Mn |
| 10 | ENDRA Life Sciences | 5.24 Mn | 4.89 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2021 | 3.92 Mn |
| Dec 31, 2021 | 3.92 Mn |